Sodium polystyrene sulfonate (SPS) is a potassium-binding resin used to treat hyperkalemia—elevated blood potassium levels. It works by exchanging sodium for potassium in the gut, lowering potassium levels. While effective, SPS carries significant risks and should be used cautiously under medical supervision.
Important Information Table
| Drug Name | Sodium Polystyrene Sulfonate (SPS) |
|---|---|
| Common Use | Hyperkalemia (high blood potassium) |
| Route | Oral or rectal |
| Onset of Action | Hours (not for emergencies) |
| Main Risks | Gastrointestinal injury, electrolyte disturbances |
| Key Contraindications | Bowel obstruction, neonates, recent GI surgery |
| Popular Brands | Kayexalate, Resonium A, Kalimate |
What Is Sodium Polystyrene Sulfonate?
Sodium polystyrene sulfonate (SPS) is a synthetic resin that binds potassium ions in exchange for sodium ions. This process occurs in the digestive tract, mostly the colon, and leads to potassium elimination through the stool. SPS has been widely used since the 1960s to treat hyperkalemia, a potentially life-threatening condition caused by high blood potassium.
The need to control potassium is critical because elevated levels affect heart rhythm, potentially leading to cardiac arrest. However, not every patient with hyperkalemia should receive SPS, and newer options are sometimes preferred. To understand when SPS is appropriate, it’s important to learn how it works and its risk profile.
How Sodium Polystyrene Sulfonate Works
Mechanism of Action
SPS is a cation-exchange resin—a complex polymer that swaps its sodium ions for potassium ions in the large intestine. The resin is not absorbed into the bloodstream; instead, it moves along the gut where it captures potassium and allows it to be expelled in feces. This gradual process reduces serum potassium over several hours.
Clinical Implications
This mechanism means SPS does not provide immediate relief from dangerously high potassium. It is unsuitable as standalone therapy in emergencies. Instead, rapid interventions (like calcium gluconate, insulin, or dialysis) are used first to stabilize the patient before or alongside SPS.
Clinical Uses and Indications
When Is SPS Used?
The main indication is non-emergent hyperkalemia. SPS is prescribed when blood potassium exceeds safe limits (usually >5.5 mmol/L) and quicker methods are unavailable, contraindicated, or as adjunctive therapy. It can be used orally or rectally depending on the patient’s condition.
- Chronic kidney disease with hyperkalemia
- Medication-induced hyperkalemia (e.g., ACE inhibitors, potassium-sparing diuretics)
- As a temporizing agent before definitive therapies
However, SPS should not delay critical interventions for life-threatening electrolyte derangement.
Limitations
SPS is not useful in situations requiring immediate potassium lowering. It is also avoided in patients with severe gastrointestinal disease due to increased risk of injury. Growing evidence questions its use in mild hyperkalemia or in settings where safer alternatives are available.
Dosage and Administration
Standard Dosing
SPS is typically started at 15 grams to 60 grams, either orally or rectally, depending on urgency and gastrointestinal status. The dose can be repeated every 4–6 hours if needed and if tolerated. Maximum total dose varies by country, institution policy, and patient risk factors.
- Oral: Mix the resin with water or syrup and administer slowly to avoid choking.
- Rectal: Used in patients who cannot swallow, but may cause more irritation.
Always monitor serum electrolytes and kidney function throughout administration.
Special Considerations
Consider individual factors such as age, kidney function, coexisting GI disease, and concurrent medications. Use lower doses or modify the route in elderly or frail patients. Never combine with agents that can cause constipation or further compromise gut motility.
Side Effects and Safety Concerns
Common Adverse Effects
- Constipation
- Nausea or vomiting
- Abdominal discomfort, bloating
- Loss of appetite
Serious Risks
- Intestinal necrosis (rare but life-threatening; higher risk with sorbitol co-administration)
- Electrolyte imbalances (hypokalemia, hypernatremia, hypocalcemia)
- Bowel obstruction or perforation, especially in at-risk patients
The FDA and global regulatory authorities have issued alerts about serious gastrointestinal injury linked to SPS, particularly in post-operative, elderly, or fragile patients. Always assess risk before prescribing SPS.
Brand Names and Formulations
SPS is sold under several brand names, most notably Kayexalate (US, Canada), Resonium A (Europe, Australia), and Kalimate (various regions). Formulations include powder, suspension, and enema solutions. Check local formularies for product availability and administration details.
Newer potassium binders, like patiromer and sodium zirconium cyclosilicate, may be preferred for long-term or non-urgent care due to improved safety profiles. However, SPS remains widely used in many countries due to cost and availability.
Guidelines and Recommendations
International guidelines (e.g., KDIGO, NICE, various national nephrology societies) advise careful use of SPS. It is generally reserved for patients with moderate hyperkalemia and no immediate danger. Monitor for adverse effects and avoid in those with increased GI risk.
Many guidelines now recommend newer agents if available, but SPS remains important where alternatives are inaccessible. Always individualize treatment, weighing benefits against potential harms.
FAQ: Sodium Polystyrene Sulfonate
- Is sodium polystyrene sulfonate safe?
- It can be effective for lowering potassium but carries risks like GI injury and severe constipation. Safety depends on careful patient selection and monitoring.
- How quickly does it lower potassium?
- SPS reduces potassium gradually over several hours. It should not be relied upon in emergency hyperkalemia management.
- What should I monitor during therapy?
- Monitor serum potassium, sodium, calcium, and for any signs of gastrointestinal distress. Adjust the dose based on response and side effects.
- Are there alternatives to SPS?
- Yes, other potassium binders (patiromer, sodium zirconium cyclosilicate) may be preferred in some settings, but SPS is still widely used globally.